Peter M. Keller
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
Papers in
- Epidemiology 47
- Mycobacterium research and diagnosis 27
- Infective Endocarditis Diagnosis and Management 10
- Pneumonia and Respiratory Infections 7
-
- Tuberculosis Research and Epidemiology 16
- Co-authors
- Oliver S. Smart (2 shared papers)G. Bricogne (2 shared papers)Thomas Womack (2 shared papers)Clemens Vonrhein (2 shared papers)W. A. Paciorek (2 shared papers)Claus Flensburg (2 shared papers)Andrew Sharff (2 shared papers)Karoline Wagner (13 shared papers)
- Journals
- Journal of Clinical Microbiology (9 papers)Blood (6 papers)Antimicrobial Agents and Chemotherapy (6 papers)Emerging infectious diseases (5 papers)Journal of Antimicrobial Chemotherapy (5 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Peter M. Keller
143 papers receiving 4.6k citations
Peter M. Keller's Hit Papers
Peers
Comparison fields: 5 of 152
- Molecular Medicine 235
- Infectious Diseases 823
- Clinical Biochemistry 265
- Endocrinology 183
- Epidemiology 896
Countries citing papers authored by Peter M. Keller
This map shows the geographic impact of Peter M. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Keller more than expected).
Fields of papers citing papers by Peter M. Keller
This network shows the impact of papers produced by Peter M. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Keller. The network helps show where Peter M. Keller may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter M. Keller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Data processing and analysis with theautoPROCtoolbox Hit paper breakdown → | 2011 | 1348 |
| 2 | 2012 | 459 | |
| 3 | 2011 | 160 | |
| 4 | 2019 | 117 | |
| 5 | 2019 | 108 | |
| 6 | 2010 | 102 | |
| 7 | 1999 | 94 | |
| 8 | 2014 | 81 | |
| 9 | 2012 | 78 | |
| 10 | 2009 | 61 | |
| 11 | 2016 | 59 | |
| 12 | 2011 | 57 | |
| 13 | 1999 | 57 | |
| 14 | 2019 | 56 | |
| 15 | 2009 | 56 | |
| 16 | 2018 | 54 | |
| 17 | 2014 | 54 | |
| 18 | 2001 | 52 | |
| 19 | 2012 | 50 | |
| 20 | 2012 | 50 |
About Peter M. Keller
Peter M. Keller is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Surgery and Immunology, having authored 150 papers that have together received 4.7k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (27 papers), Tuberculosis Research and Epidemiology (16 papers), Antibiotic Resistance in Bacteria (13 papers), Bacterial Identification and Susceptibility Testing (11 papers), Infective Endocarditis Diagnosis and Management (10 papers), Pneumonia and Respiratory Infections (7 papers), Streptococcal Infections and Treatments (6 papers) and Complement system in diseases (6 papers). The work is most often cited by research in Molecular Medicine (235 citations), Infectious Diseases (823 citations), Clinical Biochemistry (265 citations), Endocrinology (183 citations) and Epidemiology (896 citations). Peter M. Keller has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Oliver S. Smart, G. Bricogne, Thomas Womack, Clemens Vonrhein, W. A. Paciorek, Claus Flensburg, Andrew Sharff, Karoline Wagner, Guido V. Bloemberg and Erik C. Böttger. Their work appears in journals such as Journal of Clinical Microbiology, Blood, Antimicrobial Agents and Chemotherapy, Emerging infectious diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.